Enoxaparin Sodium Industry Research Report 2023
Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.
Highlights
The global Enoxaparin Sodium market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Europe is the largest market of Enoxaparin Sodium, with about 60% market share, followed by North America with about 17% market share. Currently, there are many players in this market.Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi, Amphastar, Nanjing King-friend, Sandoz and some others are playing important roles in Enoxaparin sodium injection industry. Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi and Rovi are the top 5 players of Enoxaparin Sodium, with about 85% market shares.
There are nine different dosage form of Enoxaparin Sodium. The market can be segmented into 20 mg/0.2mL, 30 mg/0.3mL, 40 mg/0.4mL, 60 mg/0.6mL, 80 mg/0.8mL, 100 mg/1mL, 120 mg/0.8mL, 150 mg/1mL, 300mg/3mL. 40 mg/0.4mL is almost the only used and efficient types and took 40% market share. By application, Hospital is the largest consumer group, with market share of 63%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin Sodium.
The Enoxaparin Sodium market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Enoxaparin Sodium market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enoxaparin Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Enoxaparin Sodium type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Enoxaparin Sodium are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Enoxaparin Sodium segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Enoxaparin Sodium market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Enoxaparin Sodium market.
Enoxaparin Sodium segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Enoxaparin Sodium market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enoxaparin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Enoxaparin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Enoxaparin Sodium industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enoxaparin Sodium.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Enoxaparin Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Enoxaparin Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Enoxaparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Highlights
The global Enoxaparin Sodium market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Europe is the largest market of Enoxaparin Sodium, with about 60% market share, followed by North America with about 17% market share. Currently, there are many players in this market.Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi, Amphastar, Nanjing King-friend, Sandoz and some others are playing important roles in Enoxaparin sodium injection industry. Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi and Rovi are the top 5 players of Enoxaparin Sodium, with about 85% market shares.
There are nine different dosage form of Enoxaparin Sodium. The market can be segmented into 20 mg/0.2mL, 30 mg/0.3mL, 40 mg/0.4mL, 60 mg/0.6mL, 80 mg/0.8mL, 100 mg/1mL, 120 mg/0.8mL, 150 mg/1mL, 300mg/3mL. 40 mg/0.4mL is almost the only used and efficient types and took 40% market share. By application, Hospital is the largest consumer group, with market share of 63%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin Sodium.
The Enoxaparin Sodium market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Enoxaparin Sodium market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enoxaparin Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Sanofi
- Teva
- Techdow (Hepalink)
- Fresenius Kabi
- Rovi
- Amphastar
- Nanjing King-friend
- Sandoz
- Apotex
- Hangzhou Jiuyuan Gene Engineering
- Cipla
- Taj Pharma
- Chengdu Baiyu Pharmaceutical
- Suzhou Erye Pharmaceutical
- Changzhou Qianhong Bio-pharma
- Hebei Changshan Biochemical Pharmaceutical
- Beijing SL Pharmaceutical
- Huadong Medicine
- Bharat Serums
- INTAS
- LUPIN
- Troikaa Pharmaceuticals
- Aristopharma
- Fosun Pharma
- SciencePharma
- PISA
Global markets are presented by Enoxaparin Sodium type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Enoxaparin Sodium are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Enoxaparin Sodium segment by Type
- 20 mg/0.2mL
- 30 mg/0.3mL
- 40 mg/0.4mL
- 60 mg/0.6mL
- 80 mg/0.8mL
- 100 mg/1mL
- 120 mg/0.8mL
- 150 mg/1mL
- 300mg/3mL
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Enoxaparin Sodium market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Enoxaparin Sodium market.
Enoxaparin Sodium segment by Application
- Hospital
- Clinic
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Enoxaparin Sodium market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enoxaparin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Enoxaparin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Enoxaparin Sodium industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enoxaparin Sodium.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Enoxaparin Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Enoxaparin Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Enoxaparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Enoxaparin Sodium Market Size (2018-2029) & (US$ Million)
2.2.2 Global Enoxaparin Sodium Sales (2018-2029)
2.2.3 Global Enoxaparin Sodium Market Average Price (2018-2029)
2.3 Enoxaparin Sodium by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 20 mg/0.2mL
1.2.3 30 mg/0.3mL
1.2.4 40 mg/0.4mL
1.2.5 60 mg/0.6mL
1.2.6 80 mg/0.8mL
1.2.7 100 mg/1mL
1.2.8 120 mg/0.8mL
1.2.9 150 mg/1mL
1.2.10 300mg/3mL
2.4 Enoxaparin Sodium by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Hospital
2.4.3 Clinic
2.4.4 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Enoxaparin Sodium Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Enoxaparin Sodium Sales (M Units) of Manufacturers (2018-2023)
3.3 Global Enoxaparin Sodium Revenue of Manufacturers (2018-2023)
3.4 Global Enoxaparin Sodium Average Price by Manufacturers (2018-2023)
3.5 Global Enoxaparin Sodium Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Enoxaparin Sodium, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Enoxaparin Sodium, Product Type & Application
3.8 Global Manufacturers of Enoxaparin Sodium, Date of Enter into This Industry
3.9 Global Enoxaparin Sodium Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Sanofi
4.1.1 Sanofi Company Information
4.1.2 Sanofi Business Overview
4.1.3 Sanofi Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Sanofi Enoxaparin Sodium Product Portfolio
4.1.5 Sanofi Recent Developments
4.2 Teva
4.2.1 Teva Company Information
4.2.2 Teva Business Overview
4.2.3 Teva Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Teva Enoxaparin Sodium Product Portfolio
4.2.5 Teva Recent Developments
4.3 Techdow (Hepalink)
4.3.1 Techdow (Hepalink) Company Information
4.3.2 Techdow (Hepalink) Business Overview
4.3.3 Techdow (Hepalink) Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Techdow (Hepalink) Enoxaparin Sodium Product Portfolio
4.3.5 Techdow (Hepalink) Recent Developments
4.4 Fresenius Kabi
4.4.1 Fresenius Kabi Company Information
4.4.2 Fresenius Kabi Business Overview
4.4.3 Fresenius Kabi Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Fresenius Kabi Enoxaparin Sodium Product Portfolio
4.4.5 Fresenius Kabi Recent Developments
4.5 Rovi
4.5.1 Rovi Company Information
4.5.2 Rovi Business Overview
4.5.3 Rovi Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Rovi Enoxaparin Sodium Product Portfolio
6.5.5 Rovi Recent Developments
4.6 Amphastar
4.6.1 Amphastar Company Information
4.6.2 Amphastar Business Overview
4.6.3 Amphastar Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Amphastar Enoxaparin Sodium Product Portfolio
4.6.5 Amphastar Recent Developments
4.7 Nanjing King-friend
4.7.1 Nanjing King-friend Company Information
4.7.2 Nanjing King-friend Business Overview
4.7.3 Nanjing King-friend Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Nanjing King-friend Enoxaparin Sodium Product Portfolio
4.7.5 Nanjing King-friend Recent Developments
6.8 Sandoz
4.8.1 Sandoz Company Information
4.8.2 Sandoz Business Overview
4.8.3 Sandoz Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Sandoz Enoxaparin Sodium Product Portfolio
4.8.5 Sandoz Recent Developments
4.9 Apotex
4.9.1 Apotex Company Information
4.9.2 Apotex Business Overview
4.9.3 Apotex Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Apotex Enoxaparin Sodium Product Portfolio
4.9.5 Apotex Recent Developments
4.10 Hangzhou Jiuyuan Gene Engineering
4.10.1 Hangzhou Jiuyuan Gene Engineering Company Information
4.10.2 Hangzhou Jiuyuan Gene Engineering Business Overview
4.10.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio
4.10.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
6.11 Cipla
6.11.1 Cipla Company Information
6.11.2 Cipla Enoxaparin Sodium Business Overview
6.11.3 Cipla Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Cipla Enoxaparin Sodium Product Portfolio
6.11.5 Cipla Recent Developments
6.12 Taj Pharma
6.12.1 Taj Pharma Company Information
6.12.2 Taj Pharma Enoxaparin Sodium Business Overview
6.12.3 Taj Pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Taj Pharma Enoxaparin Sodium Product Portfolio
6.12.5 Taj Pharma Recent Developments
6.13 Chengdu Baiyu Pharmaceutical
6.13.1 Chengdu Baiyu Pharmaceutical Company Information
6.13.2 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Business Overview
6.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio
6.13.5 Chengdu Baiyu Pharmaceutical Recent Developments
6.14 Suzhou Erye Pharmaceutical
6.14.1 Suzhou Erye Pharmaceutical Company Information
6.14.2 Suzhou Erye Pharmaceutical Enoxaparin Sodium Business Overview
6.14.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio
6.14.5 Suzhou Erye Pharmaceutical Recent Developments
6.15 Changzhou Qianhong Bio-pharma
6.15.1 Changzhou Qianhong Bio-pharma Company Information
6.15.2 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Business Overview
6.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio
6.15.5 Changzhou Qianhong Bio-pharma Recent Developments
6.16 Hebei Changshan Biochemical Pharmaceutical
6.16.1 Hebei Changshan Biochemical Pharmaceutical Company Information
6.16.2 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Business Overview
6.16.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio
6.16.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
6.17 Beijing SL Pharmaceutical
6.17.1 Beijing SL Pharmaceutical Company Information
6.17.2 Beijing SL Pharmaceutical Enoxaparin Sodium Business Overview
6.17.3 Beijing SL Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio
6.17.5 Beijing SL Pharmaceutical Recent Developments
6.18 Huadong Medicine
6.18.1 Huadong Medicine Company Information
6.18.2 Huadong Medicine Enoxaparin Sodium Business Overview
6.18.3 Huadong Medicine Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Huadong Medicine Enoxaparin Sodium Product Portfolio
6.18.5 Huadong Medicine Recent Developments
6.19 Bharat Serums
6.19.1 Bharat Serums Company Information
6.19.2 Bharat Serums Enoxaparin Sodium Business Overview
6.19.3 Bharat Serums Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Bharat Serums Enoxaparin Sodium Product Portfolio
6.19.5 Bharat Serums Recent Developments
6.20 INTAS
6.20.1 INTAS Company Information
6.20.2 INTAS Enoxaparin Sodium Business Overview
6.20.3 INTAS Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.20.4 INTAS Enoxaparin Sodium Product Portfolio
6.20.5 INTAS Recent Developments
6.21 LUPIN
6.21.1 LUPIN Company Information
6.21.2 LUPIN Enoxaparin Sodium Business Overview
6.21.3 LUPIN Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.21.4 LUPIN Enoxaparin Sodium Product Portfolio
6.21.5 LUPIN Recent Developments
6.22 Troikaa Pharmaceuticals
6.22.1 Troikaa Pharmaceuticals Company Information
6.22.2 Troikaa Pharmaceuticals Enoxaparin Sodium Business Overview
6.22.3 Troikaa Pharmaceuticals Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio
6.22.5 Troikaa Pharmaceuticals Recent Developments
6.23 Aristopharma
6.23.1 Aristopharma Company Information
6.23.2 Aristopharma Enoxaparin Sodium Business Overview
6.23.3 Aristopharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Aristopharma Enoxaparin Sodium Product Portfolio
6.23.5 Aristopharma Recent Developments
6.24 Fosun Pharma
6.24.1 Fosun Pharma Company Information
6.24.2 Fosun Pharma Enoxaparin Sodium Business Overview
6.24.3 Fosun Pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Fosun Pharma Enoxaparin Sodium Product Portfolio
6.24.5 Fosun Pharma Recent Developments
6.25 SciencePharma
6.25.1 SciencePharma Company Information
6.25.2 SciencePharma Enoxaparin Sodium Business Overview
6.25.3 SciencePharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.25.4 SciencePharma Enoxaparin Sodium Product Portfolio
6.25.5 SciencePharma Recent Developments
6.26 PISA
6.26.1 PISA Company Information
6.26.2 PISA Enoxaparin Sodium Business Overview
6.26.3 PISA Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.26.4 PISA Enoxaparin Sodium Product Portfolio
6.26.5 PISA Recent Developments
5 GLOBAL ENOXAPARIN SODIUM MARKET SCENARIO BY REGION
5.1 Global Enoxaparin Sodium Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Enoxaparin Sodium Sales by Region: 2018-2029
5.2.1 Global Enoxaparin Sodium Sales by Region: 2018-2023
5.2.2 Global Enoxaparin Sodium Sales by Region: 2024-2029
5.3 Global Enoxaparin Sodium Revenue by Region: 2018-2029
5.3.1 Global Enoxaparin Sodium Revenue by Region: 2018-2023
5.3.2 Global Enoxaparin Sodium Revenue by Region: 2024-2029
5.4 North America Enoxaparin Sodium Market Facts & Figures by Country
5.4.1 North America Enoxaparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Enoxaparin Sodium Sales by Country (2018-2029)
5.4.3 North America Enoxaparin Sodium Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Enoxaparin Sodium Market Facts & Figures by Country
5.5.1 Europe Enoxaparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Enoxaparin Sodium Sales by Country (2018-2029)
5.5.3 Europe Enoxaparin Sodium Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Enoxaparin Sodium Market Facts & Figures by Country
5.6.1 Asia Pacific Enoxaparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Enoxaparin Sodium Sales by Country (2018-2029)
5.6.3 Asia Pacific Enoxaparin Sodium Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Enoxaparin Sodium Market Facts & Figures by Country
5.7.1 Latin America Enoxaparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Enoxaparin Sodium Sales by Country (2018-2029)
5.7.3 Latin America Enoxaparin Sodium Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Enoxaparin Sodium Market Facts & Figures by Country
5.8.1 Middle East and Africa Enoxaparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Enoxaparin Sodium Sales by Country (2018-2029)
5.8.3 Middle East and Africa Enoxaparin Sodium Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Enoxaparin Sodium Sales by Type (2018-2029)
6.1.1 Global Enoxaparin Sodium Sales by Type (2018-2029) & (M Units)
6.1.2 Global Enoxaparin Sodium Sales Market Share by Type (2018-2029)
6.2 Global Enoxaparin Sodium Revenue by Type (2018-2029)
6.2.1 Global Enoxaparin Sodium Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Enoxaparin Sodium Revenue Market Share by Type (2018-2029)
6.3 Global Enoxaparin Sodium Price by Type (2018-2029)
7 SEGMENT BY APPLICATION
7.1 Global Enoxaparin Sodium Sales by Application (2018-2029)
7.1.1 Global Enoxaparin Sodium Sales by Application (2018-2029) & (M Units)
7.1.2 Global Enoxaparin Sodium Sales Market Share by Application (2018-2029)
7.2 Global Enoxaparin Sodium Revenue by Application (2018-2029)
6.2.1 Global Enoxaparin Sodium Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Enoxaparin Sodium Revenue Market Share by Application (2018-2029)
7.3 Global Enoxaparin Sodium Price by Application (2018-2029)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Enoxaparin Sodium Value Chain Analysis
8.1.1 Enoxaparin Sodium Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Enoxaparin Sodium Production Mode & Process
8.2 Enoxaparin Sodium Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Enoxaparin Sodium Distributors
8.2.3 Enoxaparin Sodium Customers
9 GLOBAL ENOXAPARIN SODIUM ANALYZING MARKET DYNAMICS
9.1 Enoxaparin Sodium Industry Trends
9.2 Enoxaparin Sodium Industry Drivers
9.3 Enoxaparin Sodium Industry Opportunities and Challenges
9.4 Enoxaparin Sodium Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Enoxaparin Sodium Market Size (2018-2029) & (US$ Million)
2.2.2 Global Enoxaparin Sodium Sales (2018-2029)
2.2.3 Global Enoxaparin Sodium Market Average Price (2018-2029)
2.3 Enoxaparin Sodium by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 20 mg/0.2mL
1.2.3 30 mg/0.3mL
1.2.4 40 mg/0.4mL
1.2.5 60 mg/0.6mL
1.2.6 80 mg/0.8mL
1.2.7 100 mg/1mL
1.2.8 120 mg/0.8mL
1.2.9 150 mg/1mL
1.2.10 300mg/3mL
2.4 Enoxaparin Sodium by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Hospital
2.4.3 Clinic
2.4.4 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Enoxaparin Sodium Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Enoxaparin Sodium Sales (M Units) of Manufacturers (2018-2023)
3.3 Global Enoxaparin Sodium Revenue of Manufacturers (2018-2023)
3.4 Global Enoxaparin Sodium Average Price by Manufacturers (2018-2023)
3.5 Global Enoxaparin Sodium Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Enoxaparin Sodium, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Enoxaparin Sodium, Product Type & Application
3.8 Global Manufacturers of Enoxaparin Sodium, Date of Enter into This Industry
3.9 Global Enoxaparin Sodium Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Sanofi
4.1.1 Sanofi Company Information
4.1.2 Sanofi Business Overview
4.1.3 Sanofi Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Sanofi Enoxaparin Sodium Product Portfolio
4.1.5 Sanofi Recent Developments
4.2 Teva
4.2.1 Teva Company Information
4.2.2 Teva Business Overview
4.2.3 Teva Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Teva Enoxaparin Sodium Product Portfolio
4.2.5 Teva Recent Developments
4.3 Techdow (Hepalink)
4.3.1 Techdow (Hepalink) Company Information
4.3.2 Techdow (Hepalink) Business Overview
4.3.3 Techdow (Hepalink) Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Techdow (Hepalink) Enoxaparin Sodium Product Portfolio
4.3.5 Techdow (Hepalink) Recent Developments
4.4 Fresenius Kabi
4.4.1 Fresenius Kabi Company Information
4.4.2 Fresenius Kabi Business Overview
4.4.3 Fresenius Kabi Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Fresenius Kabi Enoxaparin Sodium Product Portfolio
4.4.5 Fresenius Kabi Recent Developments
4.5 Rovi
4.5.1 Rovi Company Information
4.5.2 Rovi Business Overview
4.5.3 Rovi Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Rovi Enoxaparin Sodium Product Portfolio
6.5.5 Rovi Recent Developments
4.6 Amphastar
4.6.1 Amphastar Company Information
4.6.2 Amphastar Business Overview
4.6.3 Amphastar Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Amphastar Enoxaparin Sodium Product Portfolio
4.6.5 Amphastar Recent Developments
4.7 Nanjing King-friend
4.7.1 Nanjing King-friend Company Information
4.7.2 Nanjing King-friend Business Overview
4.7.3 Nanjing King-friend Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Nanjing King-friend Enoxaparin Sodium Product Portfolio
4.7.5 Nanjing King-friend Recent Developments
6.8 Sandoz
4.8.1 Sandoz Company Information
4.8.2 Sandoz Business Overview
4.8.3 Sandoz Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Sandoz Enoxaparin Sodium Product Portfolio
4.8.5 Sandoz Recent Developments
4.9 Apotex
4.9.1 Apotex Company Information
4.9.2 Apotex Business Overview
4.9.3 Apotex Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Apotex Enoxaparin Sodium Product Portfolio
4.9.5 Apotex Recent Developments
4.10 Hangzhou Jiuyuan Gene Engineering
4.10.1 Hangzhou Jiuyuan Gene Engineering Company Information
4.10.2 Hangzhou Jiuyuan Gene Engineering Business Overview
4.10.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio
4.10.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
6.11 Cipla
6.11.1 Cipla Company Information
6.11.2 Cipla Enoxaparin Sodium Business Overview
6.11.3 Cipla Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Cipla Enoxaparin Sodium Product Portfolio
6.11.5 Cipla Recent Developments
6.12 Taj Pharma
6.12.1 Taj Pharma Company Information
6.12.2 Taj Pharma Enoxaparin Sodium Business Overview
6.12.3 Taj Pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Taj Pharma Enoxaparin Sodium Product Portfolio
6.12.5 Taj Pharma Recent Developments
6.13 Chengdu Baiyu Pharmaceutical
6.13.1 Chengdu Baiyu Pharmaceutical Company Information
6.13.2 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Business Overview
6.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio
6.13.5 Chengdu Baiyu Pharmaceutical Recent Developments
6.14 Suzhou Erye Pharmaceutical
6.14.1 Suzhou Erye Pharmaceutical Company Information
6.14.2 Suzhou Erye Pharmaceutical Enoxaparin Sodium Business Overview
6.14.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio
6.14.5 Suzhou Erye Pharmaceutical Recent Developments
6.15 Changzhou Qianhong Bio-pharma
6.15.1 Changzhou Qianhong Bio-pharma Company Information
6.15.2 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Business Overview
6.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio
6.15.5 Changzhou Qianhong Bio-pharma Recent Developments
6.16 Hebei Changshan Biochemical Pharmaceutical
6.16.1 Hebei Changshan Biochemical Pharmaceutical Company Information
6.16.2 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Business Overview
6.16.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio
6.16.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
6.17 Beijing SL Pharmaceutical
6.17.1 Beijing SL Pharmaceutical Company Information
6.17.2 Beijing SL Pharmaceutical Enoxaparin Sodium Business Overview
6.17.3 Beijing SL Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio
6.17.5 Beijing SL Pharmaceutical Recent Developments
6.18 Huadong Medicine
6.18.1 Huadong Medicine Company Information
6.18.2 Huadong Medicine Enoxaparin Sodium Business Overview
6.18.3 Huadong Medicine Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Huadong Medicine Enoxaparin Sodium Product Portfolio
6.18.5 Huadong Medicine Recent Developments
6.19 Bharat Serums
6.19.1 Bharat Serums Company Information
6.19.2 Bharat Serums Enoxaparin Sodium Business Overview
6.19.3 Bharat Serums Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Bharat Serums Enoxaparin Sodium Product Portfolio
6.19.5 Bharat Serums Recent Developments
6.20 INTAS
6.20.1 INTAS Company Information
6.20.2 INTAS Enoxaparin Sodium Business Overview
6.20.3 INTAS Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.20.4 INTAS Enoxaparin Sodium Product Portfolio
6.20.5 INTAS Recent Developments
6.21 LUPIN
6.21.1 LUPIN Company Information
6.21.2 LUPIN Enoxaparin Sodium Business Overview
6.21.3 LUPIN Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.21.4 LUPIN Enoxaparin Sodium Product Portfolio
6.21.5 LUPIN Recent Developments
6.22 Troikaa Pharmaceuticals
6.22.1 Troikaa Pharmaceuticals Company Information
6.22.2 Troikaa Pharmaceuticals Enoxaparin Sodium Business Overview
6.22.3 Troikaa Pharmaceuticals Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio
6.22.5 Troikaa Pharmaceuticals Recent Developments
6.23 Aristopharma
6.23.1 Aristopharma Company Information
6.23.2 Aristopharma Enoxaparin Sodium Business Overview
6.23.3 Aristopharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Aristopharma Enoxaparin Sodium Product Portfolio
6.23.5 Aristopharma Recent Developments
6.24 Fosun Pharma
6.24.1 Fosun Pharma Company Information
6.24.2 Fosun Pharma Enoxaparin Sodium Business Overview
6.24.3 Fosun Pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Fosun Pharma Enoxaparin Sodium Product Portfolio
6.24.5 Fosun Pharma Recent Developments
6.25 SciencePharma
6.25.1 SciencePharma Company Information
6.25.2 SciencePharma Enoxaparin Sodium Business Overview
6.25.3 SciencePharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.25.4 SciencePharma Enoxaparin Sodium Product Portfolio
6.25.5 SciencePharma Recent Developments
6.26 PISA
6.26.1 PISA Company Information
6.26.2 PISA Enoxaparin Sodium Business Overview
6.26.3 PISA Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.26.4 PISA Enoxaparin Sodium Product Portfolio
6.26.5 PISA Recent Developments
5 GLOBAL ENOXAPARIN SODIUM MARKET SCENARIO BY REGION
5.1 Global Enoxaparin Sodium Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Enoxaparin Sodium Sales by Region: 2018-2029
5.2.1 Global Enoxaparin Sodium Sales by Region: 2018-2023
5.2.2 Global Enoxaparin Sodium Sales by Region: 2024-2029
5.3 Global Enoxaparin Sodium Revenue by Region: 2018-2029
5.3.1 Global Enoxaparin Sodium Revenue by Region: 2018-2023
5.3.2 Global Enoxaparin Sodium Revenue by Region: 2024-2029
5.4 North America Enoxaparin Sodium Market Facts & Figures by Country
5.4.1 North America Enoxaparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Enoxaparin Sodium Sales by Country (2018-2029)
5.4.3 North America Enoxaparin Sodium Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Enoxaparin Sodium Market Facts & Figures by Country
5.5.1 Europe Enoxaparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Enoxaparin Sodium Sales by Country (2018-2029)
5.5.3 Europe Enoxaparin Sodium Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Enoxaparin Sodium Market Facts & Figures by Country
5.6.1 Asia Pacific Enoxaparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Enoxaparin Sodium Sales by Country (2018-2029)
5.6.3 Asia Pacific Enoxaparin Sodium Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Enoxaparin Sodium Market Facts & Figures by Country
5.7.1 Latin America Enoxaparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Enoxaparin Sodium Sales by Country (2018-2029)
5.7.3 Latin America Enoxaparin Sodium Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Enoxaparin Sodium Market Facts & Figures by Country
5.8.1 Middle East and Africa Enoxaparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Enoxaparin Sodium Sales by Country (2018-2029)
5.8.3 Middle East and Africa Enoxaparin Sodium Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Enoxaparin Sodium Sales by Type (2018-2029)
6.1.1 Global Enoxaparin Sodium Sales by Type (2018-2029) & (M Units)
6.1.2 Global Enoxaparin Sodium Sales Market Share by Type (2018-2029)
6.2 Global Enoxaparin Sodium Revenue by Type (2018-2029)
6.2.1 Global Enoxaparin Sodium Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Enoxaparin Sodium Revenue Market Share by Type (2018-2029)
6.3 Global Enoxaparin Sodium Price by Type (2018-2029)
7 SEGMENT BY APPLICATION
7.1 Global Enoxaparin Sodium Sales by Application (2018-2029)
7.1.1 Global Enoxaparin Sodium Sales by Application (2018-2029) & (M Units)
7.1.2 Global Enoxaparin Sodium Sales Market Share by Application (2018-2029)
7.2 Global Enoxaparin Sodium Revenue by Application (2018-2029)
6.2.1 Global Enoxaparin Sodium Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Enoxaparin Sodium Revenue Market Share by Application (2018-2029)
7.3 Global Enoxaparin Sodium Price by Application (2018-2029)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Enoxaparin Sodium Value Chain Analysis
8.1.1 Enoxaparin Sodium Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Enoxaparin Sodium Production Mode & Process
8.2 Enoxaparin Sodium Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Enoxaparin Sodium Distributors
8.2.3 Enoxaparin Sodium Customers
9 GLOBAL ENOXAPARIN SODIUM ANALYZING MARKET DYNAMICS
9.1 Enoxaparin Sodium Industry Trends
9.2 Enoxaparin Sodium Industry Drivers
9.3 Enoxaparin Sodium Industry Opportunities and Challenges
9.4 Enoxaparin Sodium Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Enoxaparin Sodium Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Enoxaparin Sodium Sales (M Units) of Manufacturers (2018-2023)
Table 7. Global Enoxaparin Sodium Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Enoxaparin Sodium Revenue of Manufacturers (2018-2023)
Table 9. Global Enoxaparin Sodium Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Enoxaparin Sodium Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Enoxaparin Sodium Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Enoxaparin Sodium, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Enoxaparin Sodium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Sanofi Company Information
Table 17. Sanofi Business Overview
Table 18. Sanofi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Sanofi Enoxaparin Sodium Product Portfolio
Table 20. Sanofi Recent Developments
Table 21. Teva Company Information
Table 22. Teva Business Overview
Table 23. Teva Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Teva Enoxaparin Sodium Product Portfolio
Table 25. Teva Recent Developments
Table 26. Techdow (Hepalink) Company Information
Table 27. Techdow (Hepalink) Business Overview
Table 28. Techdow (Hepalink) Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Techdow (Hepalink) Enoxaparin Sodium Product Portfolio
Table 30. Techdow (Hepalink) Recent Developments
Table 31. Fresenius Kabi Company Information
Table 32. Fresenius Kabi Business Overview
Table 33. Fresenius Kabi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Fresenius Kabi Enoxaparin Sodium Product Portfolio
Table 35. Fresenius Kabi Recent Developments
Table 36. Rovi Company Information
Table 37. Rovi Business Overview
Table 38. Rovi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. Rovi Enoxaparin Sodium Product Portfolio
Table 40. Rovi Recent Developments
Table 41. Amphastar Company Information
Table 42. Amphastar Business Overview
Table 43. Amphastar Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. Amphastar Enoxaparin Sodium Product Portfolio
Table 45. Amphastar Recent Developments
Table 46. Nanjing King-friend Company Information
Table 47. Nanjing King-friend Business Overview
Table 48. Nanjing King-friend Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Nanjing King-friend Enoxaparin Sodium Product Portfolio
Table 50. Nanjing King-friend Recent Developments
Table 51. Sandoz Company Information
Table 52. Sandoz Business Overview
Table 53. Sandoz Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. Sandoz Enoxaparin Sodium Product Portfolio
Table 55. Sandoz Recent Developments
Table 56. Apotex Company Information
Table 57. Apotex Business Overview
Table 58. Apotex Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. Apotex Enoxaparin Sodium Product Portfolio
Table 60. Apotex Recent Developments
Table 61. Hangzhou Jiuyuan Gene Engineering Company Information
Table 62. Hangzhou Jiuyuan Gene Engineering Business Overview
Table 63. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 64. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio
Table 65. Hangzhou Jiuyuan Gene Engineering Recent Developments
Table 66. Cipla Company Information
Table 67. Cipla Business Overview
Table 68. Cipla Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 69. Cipla Enoxaparin Sodium Product Portfolio
Table 70. Cipla Recent Developments
Table 71. Taj Pharma Company Information
Table 72. Taj Pharma Business Overview
Table 73. Taj Pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 74. Taj Pharma Enoxaparin Sodium Product Portfolio
Table 75. Taj Pharma Recent Developments
Table 76. Chengdu Baiyu Pharmaceutical Company Information
Table 77. Chengdu Baiyu Pharmaceutical Business Overview
Table 78. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 79. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio
Table 80. Chengdu Baiyu Pharmaceutical Recent Developments
Table 81. Suzhou Erye Pharmaceutical Company Information
Table 82. Suzhou Erye Pharmaceutical Business Overview
Table 83. Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio
Table 85. Suzhou Erye Pharmaceutical Recent Developments
Table 86. Changzhou Qianhong Bio-pharma Company Information
Table 87. Changzhou Qianhong Bio-pharma Business Overview
Table 88. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio
Table 90. Changzhou Qianhong Bio-pharma Recent Developments
Table 91. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 92. Hebei Changshan Biochemical Pharmaceutical Business Overview
Table 93. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio
Table 95. Hebei Changshan Biochemical Pharmaceutical Recent Developments
Table 96. Beijing SL Pharmaceutical Company Information
Table 97. Beijing SL Pharmaceutical Business Overview
Table 98. Beijing SL Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio
Table 100. Beijing SL Pharmaceutical Recent Developments
Table 101. Huadong Medicine Company Information
Table 102. Huadong Medicine Business Overview
Table 103. Huadong Medicine Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Huadong Medicine Enoxaparin Sodium Product Portfolio
Table 105. Huadong Medicine Recent Developments
Table 106. Bharat Serums Company Information
Table 107. Bharat Serums Business Overview
Table 108. Bharat Serums Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Bharat Serums Enoxaparin Sodium Product Portfolio
Table 110. Bharat Serums Recent Developments
Table 111. INTAS Company Information
Table 112. INTAS Business Overview
Table 113. INTAS Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. INTAS Enoxaparin Sodium Product Portfolio
Table 115. INTAS Recent Developments
Table 116. LUPIN Company Information
Table 117. LUPIN Business Overview
Table 118. LUPIN Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. LUPIN Enoxaparin Sodium Product Portfolio
Table 120. LUPIN Recent Developments
Table 121. Troikaa Pharmaceuticals Company Information
Table 122. Troikaa Pharmaceuticals Business Overview
Table 123. Troikaa Pharmaceuticals Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio
Table 125. Troikaa Pharmaceuticals Recent Developments
Table 126. Aristopharma Company Information
Table 127. Aristopharma Business Overview
Table 128. Aristopharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Aristopharma Enoxaparin Sodium Product Portfolio
Table 130. Aristopharma Recent Developments
Table 131. Fosun Pharma Company Information
Table 132. Fosun Pharma Business Overview
Table 133. Fosun Pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Fosun Pharma Enoxaparin Sodium Product Portfolio
Table 135. Fosun Pharma Recent Developments
Table 136. SciencePharma Company Information
Table 137. SciencePharma Business Overview
Table 138. SciencePharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. SciencePharma Enoxaparin Sodium Product Portfolio
Table 140. SciencePharma Recent Developments
Table 141. PISA Company Information
Table 142. PISA Business Overview
Table 143. PISA Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. PISA Enoxaparin Sodium Product Portfolio
Table 145. PISA Recent Developments
Table 146. Global Enoxaparin Sodium Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 147. Global Enoxaparin Sodium Sales by Region (2018-2023) & (M Units)
Table 148. Global Enoxaparin Sodium Sales Market Share by Region (2018-2023)
Table 149. Global Enoxaparin Sodium Sales by Region (2024-2029) & (M Units)
Table 150. Global Enoxaparin Sodium Sales Market Share by Region (2024-2029)
Table 151. Global Enoxaparin Sodium Revenue by Region (2018-2023) & (US$ Million)
Table 152. Global Enoxaparin Sodium Revenue Market Share by Region (2018-2023)
Table 153. Global Enoxaparin Sodium Revenue by Region (2024-2029) & (US$ Million)
Table 154. Global Enoxaparin Sodium Revenue Market Share by Region (2024-2029)
Table 155. North America Enoxaparin Sodium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 156. North America Enoxaparin Sodium Sales by Country (2018-2023) & (M Units)
Table 157. North America Enoxaparin Sodium Sales by Country (2024-2029) & (M Units)
Table 158. North America Enoxaparin Sodium Revenue by Country (2018-2023) & (US$ Million)
Table 159. North America Enoxaparin Sodium Revenue by Country (2024-2029) & (US$ Million)
Table 160. Europe Enoxaparin Sodium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 161. Europe Enoxaparin Sodium Sales by Country (2018-2023) & (M Units)
Table 162. Europe Enoxaparin Sodium Sales by Country (2024-2029) & (M Units)
Table 163. Europe Enoxaparin Sodium Revenue by Country (2018-2023) & (US$ Million)
Table 164. Europe Enoxaparin Sodium Revenue by Country (2024-2029) & (US$ Million)
Table 165. Asia Pacific Enoxaparin Sodium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 166. Asia Pacific Enoxaparin Sodium Sales by Country (2018-2023) & (M Units)
Table 167. Asia Pacific Enoxaparin Sodium Sales by Country (2024-2029) & (M Units)
Table 168. Asia Pacific Enoxaparin Sodium Revenue by Country (2018-2023) & (US$ Million)
Table 169. Asia Pacific Enoxaparin Sodium Revenue by Country (2024-2029) & (US$ Million)
Table 170. Latin America Enoxaparin Sodium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 171. Latin America Enoxaparin Sodium Sales by Country (2018-2023) & (M Units)
Table 172. Latin America Enoxaparin Sodium Sales by Country (2024-2029) & (M Units)
Table 173. Latin America Enoxaparin Sodium Revenue by Country (2018-2023) & (US$ Million)
Table 174. Latin America Enoxaparin Sodium Revenue by Country (2024-2029) & (US$ Million)
Table 175. Middle East and Africa Enoxaparin Sodium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 176. Middle East and Africa Enoxaparin Sodium Sales by Country (2018-2023) & (M Units)
Table 177. Middle East and Africa Enoxaparin Sodium Sales by Country (2024-2029) & (M Units)
Table 178. Middle East and Africa Enoxaparin Sodium Revenue by Country (2018-2023) & (US$ Million)
Table 179. Middle East and Africa Enoxaparin Sodium Revenue by Country (2024-2029) & (US$ Million)
Table 180. Global Enoxaparin Sodium Sales by Type (2018-2023) & (M Units)
Table 181. Global Enoxaparin Sodium Sales by Type (2024-2029) & (M Units)
Table 182. Global Enoxaparin Sodium Sales Market Share by Type (2018-2023)
Table 183. Global Enoxaparin Sodium Sales Market Share by Type (2024-2029)
Table 184. Global Enoxaparin Sodium Revenue by Type (2018-2023) & (US$ Million)
Table 185. Global Enoxaparin Sodium Revenue by Type (2024-2029) & (US$ Million)
Table 186. Global Enoxaparin Sodium Revenue Market Share by Type (2018-2023)
Table 187. Global Enoxaparin Sodium Revenue Market Share by Type (2024-2029)
Table 188. Global Enoxaparin Sodium Price by Type (2018-2023) & (US$/Unit)
Table 189. Global Enoxaparin Sodium Price by Type (2024-2029) & (US$/Unit)
Table 190. Global Enoxaparin Sodium Sales by Application (2018-2023) & (M Units)
Table 191. Global Enoxaparin Sodium Sales by Application (2024-2029) & (M Units)
Table 192. Global Enoxaparin Sodium Sales Market Share by Application (2018-2023)
Table 193. Global Enoxaparin Sodium Sales Market Share by Application (2024-2029)
Table 194. Global Enoxaparin Sodium Revenue by Application (2018-2023) & (US$ Million)
Table 195. Global Enoxaparin Sodium Revenue by Application (2024-2029) & (US$ Million)
Table 196. Global Enoxaparin Sodium Revenue Market Share by Application (2018-2023)
Table 197. Global Enoxaparin Sodium Revenue Market Share by Application (2024-2029)
Table 198. Global Enoxaparin Sodium Price by Application (2018-2023) & (US$/Unit)
Table 199. Global Enoxaparin Sodium Price by Application (2024-2029) & (US$/Unit)
Table 200. Key Raw Materials
Table 201. Raw Materials Key Suppliers
Table 202. Enoxaparin Sodium Distributors List
Table 203. Enoxaparin Sodium Customers List
Table 204. Enoxaparin Sodium Industry Trends
Table 205. Enoxaparin Sodium Industry Drivers
Table 206. Enoxaparin Sodium Industry Restraints
Table 207. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Enoxaparin Sodium Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Enoxaparin Sodium Sales (M Units) of Manufacturers (2018-2023)
Table 7. Global Enoxaparin Sodium Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Enoxaparin Sodium Revenue of Manufacturers (2018-2023)
Table 9. Global Enoxaparin Sodium Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Enoxaparin Sodium Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Enoxaparin Sodium Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Enoxaparin Sodium, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Enoxaparin Sodium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Sanofi Company Information
Table 17. Sanofi Business Overview
Table 18. Sanofi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Sanofi Enoxaparin Sodium Product Portfolio
Table 20. Sanofi Recent Developments
Table 21. Teva Company Information
Table 22. Teva Business Overview
Table 23. Teva Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Teva Enoxaparin Sodium Product Portfolio
Table 25. Teva Recent Developments
Table 26. Techdow (Hepalink) Company Information
Table 27. Techdow (Hepalink) Business Overview
Table 28. Techdow (Hepalink) Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Techdow (Hepalink) Enoxaparin Sodium Product Portfolio
Table 30. Techdow (Hepalink) Recent Developments
Table 31. Fresenius Kabi Company Information
Table 32. Fresenius Kabi Business Overview
Table 33. Fresenius Kabi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Fresenius Kabi Enoxaparin Sodium Product Portfolio
Table 35. Fresenius Kabi Recent Developments
Table 36. Rovi Company Information
Table 37. Rovi Business Overview
Table 38. Rovi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. Rovi Enoxaparin Sodium Product Portfolio
Table 40. Rovi Recent Developments
Table 41. Amphastar Company Information
Table 42. Amphastar Business Overview
Table 43. Amphastar Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. Amphastar Enoxaparin Sodium Product Portfolio
Table 45. Amphastar Recent Developments
Table 46. Nanjing King-friend Company Information
Table 47. Nanjing King-friend Business Overview
Table 48. Nanjing King-friend Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Nanjing King-friend Enoxaparin Sodium Product Portfolio
Table 50. Nanjing King-friend Recent Developments
Table 51. Sandoz Company Information
Table 52. Sandoz Business Overview
Table 53. Sandoz Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. Sandoz Enoxaparin Sodium Product Portfolio
Table 55. Sandoz Recent Developments
Table 56. Apotex Company Information
Table 57. Apotex Business Overview
Table 58. Apotex Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. Apotex Enoxaparin Sodium Product Portfolio
Table 60. Apotex Recent Developments
Table 61. Hangzhou Jiuyuan Gene Engineering Company Information
Table 62. Hangzhou Jiuyuan Gene Engineering Business Overview
Table 63. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 64. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio
Table 65. Hangzhou Jiuyuan Gene Engineering Recent Developments
Table 66. Cipla Company Information
Table 67. Cipla Business Overview
Table 68. Cipla Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 69. Cipla Enoxaparin Sodium Product Portfolio
Table 70. Cipla Recent Developments
Table 71. Taj Pharma Company Information
Table 72. Taj Pharma Business Overview
Table 73. Taj Pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 74. Taj Pharma Enoxaparin Sodium Product Portfolio
Table 75. Taj Pharma Recent Developments
Table 76. Chengdu Baiyu Pharmaceutical Company Information
Table 77. Chengdu Baiyu Pharmaceutical Business Overview
Table 78. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 79. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio
Table 80. Chengdu Baiyu Pharmaceutical Recent Developments
Table 81. Suzhou Erye Pharmaceutical Company Information
Table 82. Suzhou Erye Pharmaceutical Business Overview
Table 83. Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio
Table 85. Suzhou Erye Pharmaceutical Recent Developments
Table 86. Changzhou Qianhong Bio-pharma Company Information
Table 87. Changzhou Qianhong Bio-pharma Business Overview
Table 88. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio
Table 90. Changzhou Qianhong Bio-pharma Recent Developments
Table 91. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 92. Hebei Changshan Biochemical Pharmaceutical Business Overview
Table 93. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio
Table 95. Hebei Changshan Biochemical Pharmaceutical Recent Developments
Table 96. Beijing SL Pharmaceutical Company Information
Table 97. Beijing SL Pharmaceutical Business Overview
Table 98. Beijing SL Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio
Table 100. Beijing SL Pharmaceutical Recent Developments
Table 101. Huadong Medicine Company Information
Table 102. Huadong Medicine Business Overview
Table 103. Huadong Medicine Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Huadong Medicine Enoxaparin Sodium Product Portfolio
Table 105. Huadong Medicine Recent Developments
Table 106. Bharat Serums Company Information
Table 107. Bharat Serums Business Overview
Table 108. Bharat Serums Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Bharat Serums Enoxaparin Sodium Product Portfolio
Table 110. Bharat Serums Recent Developments
Table 111. INTAS Company Information
Table 112. INTAS Business Overview
Table 113. INTAS Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. INTAS Enoxaparin Sodium Product Portfolio
Table 115. INTAS Recent Developments
Table 116. LUPIN Company Information
Table 117. LUPIN Business Overview
Table 118. LUPIN Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. LUPIN Enoxaparin Sodium Product Portfolio
Table 120. LUPIN Recent Developments
Table 121. Troikaa Pharmaceuticals Company Information
Table 122. Troikaa Pharmaceuticals Business Overview
Table 123. Troikaa Pharmaceuticals Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio
Table 125. Troikaa Pharmaceuticals Recent Developments
Table 126. Aristopharma Company Information
Table 127. Aristopharma Business Overview
Table 128. Aristopharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Aristopharma Enoxaparin Sodium Product Portfolio
Table 130. Aristopharma Recent Developments
Table 131. Fosun Pharma Company Information
Table 132. Fosun Pharma Business Overview
Table 133. Fosun Pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Fosun Pharma Enoxaparin Sodium Product Portfolio
Table 135. Fosun Pharma Recent Developments
Table 136. SciencePharma Company Information
Table 137. SciencePharma Business Overview
Table 138. SciencePharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. SciencePharma Enoxaparin Sodium Product Portfolio
Table 140. SciencePharma Recent Developments
Table 141. PISA Company Information
Table 142. PISA Business Overview
Table 143. PISA Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. PISA Enoxaparin Sodium Product Portfolio
Table 145. PISA Recent Developments
Table 146. Global Enoxaparin Sodium Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 147. Global Enoxaparin Sodium Sales by Region (2018-2023) & (M Units)
Table 148. Global Enoxaparin Sodium Sales Market Share by Region (2018-2023)
Table 149. Global Enoxaparin Sodium Sales by Region (2024-2029) & (M Units)
Table 150. Global Enoxaparin Sodium Sales Market Share by Region (2024-2029)
Table 151. Global Enoxaparin Sodium Revenue by Region (2018-2023) & (US$ Million)
Table 152. Global Enoxaparin Sodium Revenue Market Share by Region (2018-2023)
Table 153. Global Enoxaparin Sodium Revenue by Region (2024-2029) & (US$ Million)
Table 154. Global Enoxaparin Sodium Revenue Market Share by Region (2024-2029)
Table 155. North America Enoxaparin Sodium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 156. North America Enoxaparin Sodium Sales by Country (2018-2023) & (M Units)
Table 157. North America Enoxaparin Sodium Sales by Country (2024-2029) & (M Units)
Table 158. North America Enoxaparin Sodium Revenue by Country (2018-2023) & (US$ Million)
Table 159. North America Enoxaparin Sodium Revenue by Country (2024-2029) & (US$ Million)
Table 160. Europe Enoxaparin Sodium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 161. Europe Enoxaparin Sodium Sales by Country (2018-2023) & (M Units)
Table 162. Europe Enoxaparin Sodium Sales by Country (2024-2029) & (M Units)
Table 163. Europe Enoxaparin Sodium Revenue by Country (2018-2023) & (US$ Million)
Table 164. Europe Enoxaparin Sodium Revenue by Country (2024-2029) & (US$ Million)
Table 165. Asia Pacific Enoxaparin Sodium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 166. Asia Pacific Enoxaparin Sodium Sales by Country (2018-2023) & (M Units)
Table 167. Asia Pacific Enoxaparin Sodium Sales by Country (2024-2029) & (M Units)
Table 168. Asia Pacific Enoxaparin Sodium Revenue by Country (2018-2023) & (US$ Million)
Table 169. Asia Pacific Enoxaparin Sodium Revenue by Country (2024-2029) & (US$ Million)
Table 170. Latin America Enoxaparin Sodium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 171. Latin America Enoxaparin Sodium Sales by Country (2018-2023) & (M Units)
Table 172. Latin America Enoxaparin Sodium Sales by Country (2024-2029) & (M Units)
Table 173. Latin America Enoxaparin Sodium Revenue by Country (2018-2023) & (US$ Million)
Table 174. Latin America Enoxaparin Sodium Revenue by Country (2024-2029) & (US$ Million)
Table 175. Middle East and Africa Enoxaparin Sodium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 176. Middle East and Africa Enoxaparin Sodium Sales by Country (2018-2023) & (M Units)
Table 177. Middle East and Africa Enoxaparin Sodium Sales by Country (2024-2029) & (M Units)
Table 178. Middle East and Africa Enoxaparin Sodium Revenue by Country (2018-2023) & (US$ Million)
Table 179. Middle East and Africa Enoxaparin Sodium Revenue by Country (2024-2029) & (US$ Million)
Table 180. Global Enoxaparin Sodium Sales by Type (2018-2023) & (M Units)
Table 181. Global Enoxaparin Sodium Sales by Type (2024-2029) & (M Units)
Table 182. Global Enoxaparin Sodium Sales Market Share by Type (2018-2023)
Table 183. Global Enoxaparin Sodium Sales Market Share by Type (2024-2029)
Table 184. Global Enoxaparin Sodium Revenue by Type (2018-2023) & (US$ Million)
Table 185. Global Enoxaparin Sodium Revenue by Type (2024-2029) & (US$ Million)
Table 186. Global Enoxaparin Sodium Revenue Market Share by Type (2018-2023)
Table 187. Global Enoxaparin Sodium Revenue Market Share by Type (2024-2029)
Table 188. Global Enoxaparin Sodium Price by Type (2018-2023) & (US$/Unit)
Table 189. Global Enoxaparin Sodium Price by Type (2024-2029) & (US$/Unit)
Table 190. Global Enoxaparin Sodium Sales by Application (2018-2023) & (M Units)
Table 191. Global Enoxaparin Sodium Sales by Application (2024-2029) & (M Units)
Table 192. Global Enoxaparin Sodium Sales Market Share by Application (2018-2023)
Table 193. Global Enoxaparin Sodium Sales Market Share by Application (2024-2029)
Table 194. Global Enoxaparin Sodium Revenue by Application (2018-2023) & (US$ Million)
Table 195. Global Enoxaparin Sodium Revenue by Application (2024-2029) & (US$ Million)
Table 196. Global Enoxaparin Sodium Revenue Market Share by Application (2018-2023)
Table 197. Global Enoxaparin Sodium Revenue Market Share by Application (2024-2029)
Table 198. Global Enoxaparin Sodium Price by Application (2018-2023) & (US$/Unit)
Table 199. Global Enoxaparin Sodium Price by Application (2024-2029) & (US$/Unit)
Table 200. Key Raw Materials
Table 201. Raw Materials Key Suppliers
Table 202. Enoxaparin Sodium Distributors List
Table 203. Enoxaparin Sodium Customers List
Table 204. Enoxaparin Sodium Industry Trends
Table 205. Enoxaparin Sodium Industry Drivers
Table 206. Enoxaparin Sodium Industry Restraints
Table 207. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Enoxaparin SodiumProduct Picture
Figure 5. Global Enoxaparin Sodium Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Enoxaparin Sodium Market Size (2018-2029) & (US$ Million)
Figure 7. Global Enoxaparin Sodium Sales (2018-2029) & (M Units)
Figure 8. Global Enoxaparin Sodium Average Price (US$/Unit) & (2018-2029)
Figure 9. 20 mg/0.2mL Product Picture
Figure 10. 30 mg/0.3mL Product Picture
Figure 11. 40 mg/0.4mL Product Picture
Figure 12. 60 mg/0.6mL Product Picture
Figure 13. 80 mg/0.8mL Product Picture
Figure 14. 100 mg/1mL Product Picture
Figure 15. 120 mg/0.8mL Product Picture
Figure 16. 150 mg/1mL Product Picture
Figure 17. 300mg/3mL Product Picture
Figure 18. Hospital Product Picture
Figure 19. Clinic Product Picture
Figure 20. Others Product Picture
Figure 21. Global Enoxaparin Sodium Revenue Share by Manufacturers in 2022
Figure 22. Global Manufacturers of Enoxaparin Sodium, Manufacturing Sites & Headquarters
Figure 23. Global Manufacturers of Enoxaparin Sodium, Date of Enter into This Industry
Figure 24. Global Top 5 and 10 Enoxaparin Sodium Players Market Share by Revenue in 2022
Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Global Enoxaparin Sodium Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 27. Global Enoxaparin Sodium Sales by Region in 2022
Figure 28. Global Enoxaparin Sodium Revenue by Region in 2022
Figure 29. North America Enoxaparin Sodium Market Size by Country in 2022
Figure 30. North America Enoxaparin Sodium Sales Market Share by Country (2018-2029)
Figure 31. North America Enoxaparin Sodium Revenue Market Share by Country (2018-2029)
Figure 32. United States Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Canada Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Europe Enoxaparin Sodium Market Size by Country in 2022
Figure 35. Europe Enoxaparin Sodium Sales Market Share by Country (2018-2029)
Figure 36. Europe Enoxaparin Sodium Revenue Market Share by Country (2018-2029)
Figure 37. Germany Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. France Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. U.K. Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Italy Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Russia Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Asia Pacific Enoxaparin Sodium Market Size by Country in 2022
Figure 43. Asia Pacific Enoxaparin Sodium Sales Market Share by Country (2018-2029)
Figure 44. Asia Pacific Enoxaparin Sodium Revenue Market Share by Country (2018-2029)
Figure 45. China Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Japan Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. South Korea Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. India Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Australia Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. China Taiwan Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Indonesia Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Thailand Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Malaysia Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Latin America Enoxaparin Sodium Market Size by Country in 2022
Figure 55. Latin America Enoxaparin Sodium Sales Market Share by Country (2018-2029)
Figure 56. Latin America Enoxaparin Sodium Revenue Market Share by Country (2018-2029)
Figure 57. Mexico Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Brazil Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Argentina Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Middle East and Africa Enoxaparin Sodium Market Size by Country in 2022
Figure 61. Middle East and Africa Enoxaparin Sodium Sales Market Share by Country (2018-2029)
Figure 62. Middle East and Africa Enoxaparin Sodium Revenue Market Share by Country (2018-2029)
Figure 63. Turkey Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 64. Saudi Arabia Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 65. UAE Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 66. Global Enoxaparin Sodium Sales Market Share by Type (2018-2029)
Figure 67. Global Enoxaparin Sodium Revenue Market Share by Type (2018-2029)
Figure 68. Global Enoxaparin Sodium Price (US$/Unit) by Type (2018-2029)
Figure 69. Global Enoxaparin Sodium Sales Market Share by Application (2018-2029)
Figure 70. Global Enoxaparin Sodium Revenue Market Share by Application (2018-2029)
Figure 71. Global Enoxaparin Sodium Price (US$/Unit) by Application (2018-2029)
Figure 72. Enoxaparin Sodium Value Chain
Figure 73. Enoxaparin Sodium Production Mode & Process
Figure 74. Direct Comparison with Distribution Share
Figure 75. Distributors Profiles
Figure 76. Enoxaparin Sodium Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Enoxaparin SodiumProduct Picture
Figure 5. Global Enoxaparin Sodium Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Enoxaparin Sodium Market Size (2018-2029) & (US$ Million)
Figure 7. Global Enoxaparin Sodium Sales (2018-2029) & (M Units)
Figure 8. Global Enoxaparin Sodium Average Price (US$/Unit) & (2018-2029)
Figure 9. 20 mg/0.2mL Product Picture
Figure 10. 30 mg/0.3mL Product Picture
Figure 11. 40 mg/0.4mL Product Picture
Figure 12. 60 mg/0.6mL Product Picture
Figure 13. 80 mg/0.8mL Product Picture
Figure 14. 100 mg/1mL Product Picture
Figure 15. 120 mg/0.8mL Product Picture
Figure 16. 150 mg/1mL Product Picture
Figure 17. 300mg/3mL Product Picture
Figure 18. Hospital Product Picture
Figure 19. Clinic Product Picture
Figure 20. Others Product Picture
Figure 21. Global Enoxaparin Sodium Revenue Share by Manufacturers in 2022
Figure 22. Global Manufacturers of Enoxaparin Sodium, Manufacturing Sites & Headquarters
Figure 23. Global Manufacturers of Enoxaparin Sodium, Date of Enter into This Industry
Figure 24. Global Top 5 and 10 Enoxaparin Sodium Players Market Share by Revenue in 2022
Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Global Enoxaparin Sodium Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 27. Global Enoxaparin Sodium Sales by Region in 2022
Figure 28. Global Enoxaparin Sodium Revenue by Region in 2022
Figure 29. North America Enoxaparin Sodium Market Size by Country in 2022
Figure 30. North America Enoxaparin Sodium Sales Market Share by Country (2018-2029)
Figure 31. North America Enoxaparin Sodium Revenue Market Share by Country (2018-2029)
Figure 32. United States Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Canada Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Europe Enoxaparin Sodium Market Size by Country in 2022
Figure 35. Europe Enoxaparin Sodium Sales Market Share by Country (2018-2029)
Figure 36. Europe Enoxaparin Sodium Revenue Market Share by Country (2018-2029)
Figure 37. Germany Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. France Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. U.K. Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Italy Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Russia Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Asia Pacific Enoxaparin Sodium Market Size by Country in 2022
Figure 43. Asia Pacific Enoxaparin Sodium Sales Market Share by Country (2018-2029)
Figure 44. Asia Pacific Enoxaparin Sodium Revenue Market Share by Country (2018-2029)
Figure 45. China Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Japan Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. South Korea Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. India Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Australia Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. China Taiwan Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Indonesia Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Thailand Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Malaysia Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Latin America Enoxaparin Sodium Market Size by Country in 2022
Figure 55. Latin America Enoxaparin Sodium Sales Market Share by Country (2018-2029)
Figure 56. Latin America Enoxaparin Sodium Revenue Market Share by Country (2018-2029)
Figure 57. Mexico Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Brazil Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Argentina Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Middle East and Africa Enoxaparin Sodium Market Size by Country in 2022
Figure 61. Middle East and Africa Enoxaparin Sodium Sales Market Share by Country (2018-2029)
Figure 62. Middle East and Africa Enoxaparin Sodium Revenue Market Share by Country (2018-2029)
Figure 63. Turkey Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 64. Saudi Arabia Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 65. UAE Enoxaparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 66. Global Enoxaparin Sodium Sales Market Share by Type (2018-2029)
Figure 67. Global Enoxaparin Sodium Revenue Market Share by Type (2018-2029)
Figure 68. Global Enoxaparin Sodium Price (US$/Unit) by Type (2018-2029)
Figure 69. Global Enoxaparin Sodium Sales Market Share by Application (2018-2029)
Figure 70. Global Enoxaparin Sodium Revenue Market Share by Application (2018-2029)
Figure 71. Global Enoxaparin Sodium Price (US$/Unit) by Application (2018-2029)
Figure 72. Enoxaparin Sodium Value Chain
Figure 73. Enoxaparin Sodium Production Mode & Process
Figure 74. Direct Comparison with Distribution Share
Figure 75. Distributors Profiles
Figure 76. Enoxaparin Sodium Industry Opportunities and Challenges
